Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CFO and COO
-
Stock Symbol
-
VIRX on Nasdaq
Daniel R. Chevallard - trading volume in the past year for Viracta Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
102K |
$74.9K |
$0.73 |
Feb 27, 2024 |
Direct |
|
|
| Restricted Stock Units |
34.4K |
$17K |
$0.49 |
Feb 25, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
200K |
|
|
Mar 12, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.